Business, energy, technology, markets and global industry news from Business News Today

Rozanolixizumab

Features & Analysis

Why destroying IgG faster can treat myasthenia gravis without depleting B cells

FcRn normally rescues IgG antibodies from intracellular destruction and returns them to circulation. Blocking that recycling pathway accelerates IgG clearance, including pathogenic autoantibodies, without directly eliminating the B cells that produced them.

Read More